Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic Malignancies

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2016.04.013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

An Identical Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic (ALLO) Hematopoietic Stem Cell Transplantation (HSCT) in 222 Patients With Hematologic Malignancies: A Monocenter Experience

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Toxicity and Efficacy of Busulfan and Fludarabine Myeloablative Conditioning for HLA-identical Sibling Allogeneic Hematopoietic Cell Transplantation in AML and MDS

Bone Marrow Transplantation
TransplantationHematology
2016English

The Dilemma of Conditioning Intensity: When Does Myeloablative Conditioning Improve Outcomes for Allogeneic Hematopoietic Cell Transplantation?

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Thiotepa and Fractionated TBI Conditioning Prior to Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies: A Phase II Single Institution Trial

Bone Marrow Transplantation
TransplantationHematology
2004English

Myeloablative Conditioning for Hematopoietic Stem-Cell Transplantation in Patients With Non-Malignant Diseases

Bone Marrow Transplantation
TransplantationHematology
2006English

Role of Conditioning Regimens in Pediatric Hematopoietic Stem Cell Transplant for Malignant Disorders: Reduced Toxicity Versus Standard Myeloablative Regimens

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Myeloablative Doses of Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation in Non-Hodgkin'S Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Long-Term Outcome of HLA-haploidentical Hematopoietic Stem Cell Transplantation Without in Vitro T-Cell Depletion Based on an FBCA Conditioning Regimen for Hematologic Malignancies

Bone Marrow Transplantation
TransplantationHematology
2015English

Hematopoietic Stem Cell Transplantation for Childhood Myeloid Malignancies After High-Dose Thiotepa, Busulfan and Cyclophosphamide

Bone Marrow Transplantation
TransplantationHematology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy